In a report released yesterday, Ben Hendrix from RBC Capital reiterated a Buy rating on Elevance Health (ELV – Research Report), with a price ...
Financial writer discusses RBC Capital's bullish outlook on Carvana, citing upside potential in retail unit estimates and path to durable free cash flow.
RBC Capital analyst Ken Herbert downgraded V2X (VVX) to Sector Perform from Outperform with a price target of $58, down from $70. With the incoming Trump presidency, the government services sector ...
Investing.com -- RBC Capital Markets on Monday upgraded Carvana (NYSE:CVNA) shares to Outperform, and lifted the target price to $280 from $270. According to the firm’s analysts, following ...
Investors in fertilizer equities can expect steady prices and good cash generation, according to analysts at RBC Capital Markets.
RBC Capital upgraded Hexcel (HXL) to Outperform from Sector Perform with a price target of $74, up from $68. While it is early to have high conviction in an aerospace recovery, Hexcel is one ...
However, its 2025 costs and capital expenditure guidance exceeded analyst expectations as well as its own previous guidance. For full-year 2025, Hochschild expects capital expenditure between $197 ...
Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...
Meta CEO Mark Zuckerberg announced this morning that the company intends to spend $60B-$65B in capital expenditures for the year, which RBC ...